2.6 Diagnostic Considerations

Differential Diagnosis: Substance-Induced vs. Independent Disorders

A central diagnostic skill for the ADC counselor is distinguishing a substance-induced disorder from an independent (primary) psychiatric disorder. DSM-5-TR allows three working categorizations of psychiatric symptoms in someone with a substance use disorder:

1. Substance intoxication or withdrawal — symptoms appear during active use or withdrawal and are explained by the pharmacology.
2. Substance-induced disorder — symptoms (depression, anxiety, psychosis, sleep disturbance) are clinically significant and exceed expected intoxication/withdrawal, but are caused by the substance.
3. Independent / primary disorder — symptoms exist outside the context of substance use and persist during abstinence.

The Rule of Timing

The widely taught clinical rule is that substance-induced symptoms typically resolve within about four weeks of sustained abstinence. Symptoms that persist beyond that window — or that clearly predate substance use — are more likely to reflect an independent disorder requiring its own treatment.

This four-week rule is a heuristic, not an absolute. Cannabis-induced psychotic symptoms and stimulant-induced mood symptoms can take longer to clear, and a documented history of symptoms predating first use can support an independent diagnosis sooner. Onset, course, and family history together inform the formulation.

Co-Occurring Disorder Assessment

Roughly half of people with a serious mental illness also have a substance use disorder. Best practice is integrated assessment: screen for mental health symptoms in SUD settings, screen for substance use in mental health settings, and use a single-clinician or single-team formulation rather than ping-ponging the client between siloed providers.

Common brief mental health screeners paired with SUD assessment:

• PHQ-9 — depression severity (0-27 scale; >= 10 moderate, >= 15 moderately severe, >= 20 severe).
• GAD-7 — generalized anxiety (0-21 scale; >= 10 moderate, >= 15 severe).
• PCL-5 — PTSD symptoms aligned with DSM-5-TR criteria.

Trauma Screening: PTSD and ACEs

Trauma exposure is strongly associated with SUD development and relapse risk. Two tools dominate the exam:

• PCL-5 (PTSD Checklist for DSM-5) — 20 items structured to DSM-5-TR PTSD criteria; commonly used as a brief PTSD severity measure.
• ACE Questionnaire (Adverse Childhood Experiences) — 10 yes/no items covering abuse, neglect, and household dysfunction before age 18. ACE scores of 4 or higher are associated with markedly elevated risk of SUD, depression, suicide attempt, and chronic disease.

Trauma-informed assessment means asking with care, normalizing the question, watching for activation, and offering grounding skills before, during, and after disclosure. Avoid forcing detailed trauma narratives at intake; the purpose of trauma screening at assessment is detection and safety planning, not exposure therapy.

Suicide and Violence Risk Assessment

Suicide risk must be assessed at intake and at transitions for every SUD client, because SUD is one of the strongest acute risk factors for suicide.

Columbia Suicide Severity Rating Scale (C-SSRS)

The C-SSRS is the most widely tested suicide risk tool and is used across emergency, primary care, behavioral health, and military settings. It evaluates:

• Ideation severity on a 1-5 ladder, from a passive wish to die through ideation with plan and intent.
• Ideation intensity — frequency, duration, controllability, deterrents, and reasons.
• Behavior — actual, interrupted, aborted, and preparatory acts, plus non-suicidal self-injury.

A positive C-SSRS triggers a documented safety plan (means restriction, coping strategies, supports, professional contacts, crisis line) and may justify a higher level of care (a Dimension 3 risk).

Violence Risk

Violence risk assessment parallels suicide assessment: ideation, plan, means, intent, history, and an identifiable target. When duty-to-warn (Tarasoff) thresholds are met — an identifiable victim and a credible, imminent threat — confidentiality protections (including 42 CFR Part 2) yield to the duty to protect.

Motivational Assessment

Motivation corresponds to Dimension 4 of the ASAM Criteria. Two instruments operationalize it:

Readiness Ruler

The Readiness Ruler is a 0-10 visual analog scale on which clients rate the importance of change, their confidence in their ability to change, and their readiness to change right now. It is fast, validated, and produces an immediately usable number for treatment planning. The follow-up question — 'Why did you choose a 5 instead of a 2?' — elicits change talk and is a core motivational interviewing technique.

URICA (University of Rhode Island Change Assessment)

The URICA is a 24- or 32-item self-report instrument that scores the client on the stages of change from the Transtheoretical Model: Precontemplation, Contemplation, Action, and Maintenance (URICA does not separately score Preparation). It yields a readiness composite and tracks movement across stages over time.

Motivational assessment is not a one-time event. Reassess at transitions, after slips or relapses, and at discharge — motivation shifts in both directions and should drive intervention selection (motivational interviewing for early stages, action-oriented CBT for the action and maintenance stages).

Common Exam Traps

• Substance-induced is not the same as primary; the four-week abstinence rule is the most-tested clinical heuristic.
• The C-SSRS is the most commonly named suicide screener; do not confuse it with PHQ-9 Item 9, which is a single suicide question, not a full screener.
• ACE scores predict lifetime SUD and health risk; they do not by themselves diagnose PTSD.
• The Readiness Ruler and URICA are assessment tools for motivation; motivational interviewing itself is the intervention that flows from those scores.
• A positive trauma screen does not justify immediate exposure work; assess, stabilize, then sequence trauma treatment with the client's consent.